

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders. Among its major competitors, Viking Therapeutics is ranked in 3rd place for NPS while Eli Lilly and Company is 1st, and ViaCyte is 2nd.
Viking Therapeutics's Net Promoter Score (NPS) is a -100 with 0% Promoters, 0% Passives, and 100% Detractors. Net Promoter Score tracks whether Viking Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 0% | Passives |
| 100% | Detractors |
| Summary | Date | Score |
|---|---|---|
Nov 2024 -100 | Nov 2024 | -100 |
Viking Therapeutics is ranked third for NPS among its competitors. Eli Lilly and Company and ViaCyte come in first and second, with Pfenex coming in at #4.
![]() Viking Therapeutics | ![]() Eli Lilly and Company | ![]() ViaCyte | ![]() Pfenex | |
| Global Ranking | #- | #192 | #- | #- |
| NPS | -100 | 26 | -100 | - |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | - | - |
| Valuation Updated every 24 hours for public companies | - | $179.16B | $510.00M | $437.28M |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, Viking Therapeutics's NPS is rated right below ViaCyte.
| COMPANY | NPS Score | |
|---|---|---|
![]() | Eli Lilly and Company | 26 |
![]() | ViaCyte | -100 |
![]() | Viking Therapeutics | -100 |
Customer Loyalty is a strong indicator of whether or not a customer will choose a brand repeatedly over a competitor that offers similar products/services.
10% of Viking Therapeutics users/customers answered "Yes" when asked: "Would you consider yourself a loyal user/customer?"
Sign Up to see the full customer demographics data and the people that answered "Yes" when asked "Would you consider yourself a loyal user/customer?"
Compared to its competitors, Viking Therapeutics's Customer Loyalty score is rated right above ViaCyte, and is preceded by Eli Lilly and Company.
| COMPANY | Customer Loyalty Score | |
|---|---|---|
![]() | Eli Lilly and Company | 76% |
![]() | Viking Therapeutics | 10% |
![]() | ViaCyte | N/A |
Viking Therapeutics has an overall Product Quality score of 2.5 out of 5 stars rated by its users and customers.
Sign Up to unlock Viking Therapeutics' overall Product Quality score rated by its users and customers.
Viking Therapeutics’s product quality score is a 2.5 out of 5 as rated by its users and customers.
Compared to its competitors, Viking Therapeutics's Product Quality score is rated right above ViaCyte, and is preceded by Eli Lilly and Company.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | Eli Lilly and Company | 3.8/5 |
![]() | Viking Therapeutics | 2.5/5 |
![]() | ViaCyte | N/A |
Viking Therapeutics has a value for money and ROI score of 2.5 out of 5 stars rated by its users and customers.
Sign Up to unlock Viking Therapeutics' overall ROI score rated by its users and customers.
Compared to its competitors, Viking Therapeutics's ROI score is rated right above ViaCyte, and is preceded by Eli Lilly and Company.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | Eli Lilly and Company | 3.9/5 |
![]() | Viking Therapeutics | 2.5/5 |
![]() | ViaCyte | N/A |
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, Viking Therapeutics's Customer Satisfaction score is rated right below ViaCyte.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | Eli Lilly and Company | 69% |
![]() | ViaCyte | 0% |
![]() | Viking Therapeutics | 0% |
Viking Therapeutics has an overall Customer Service score of 2.5 out of 5 stars rated by its users and customers.
Sign Up to unlock Viking Therapeutics' overall Customer Service score rated by its users and customers.
Suite 50, California, PA
http://vikingtherapeutics.com
(858) 550-7810
Compared to its competitors, Viking Therapeutics's Customer Service score is rated right above ViaCyte, and is preceded by Eli Lilly and Company.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | Eli Lilly and Company | 3.8/5 |
![]() | Viking Therapeutics | 2.5/5 |
![]() | ViaCyte | N/A |